The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Business Wire

Philip Morris International Inc. (“PMI”) Acquires Units of Medicago Inc. as Part of Public Offering

Tuesday, April 05, 2011

Philip Morris International Inc. (“PMI”) Acquires Units of Medicago Inc. as Part of Public Offering09:15 EDT Tuesday, April 05, 2011 NEW YORK (Business Wire) -- Philip Morris International Inc. (NYSE / Euronext Paris: PM) announces that is has acquired CAD $8.7 million of units of Medicago Inc. (“Medicago”) pursuant to Medicago's previously-announced CAD $17.4 million equity offering (the “Offering”). Each unit was issued at a price of CAD $0.51 and consists of one common share of Medicago and 0.25 of one common share purchase warrant with each warrant exercisable at any time at a price of CAD $0.75 per common share for a period of 24 months following the date of closing of the Offering. As part of the Offering, Philip Morris Investments B.V. (“PM Investments”), a wholly-owned indirect subsidiary of PMI, acquired ownership of 17,058,800 units which represent 9.86% of the issued and outstanding common shares of Medicago, when calculated after giving effect to the Offering on a non-fully diluted basis. Pursuant to this transaction, the current holding of PM Investments in Medicago now consists of 64,058,800 common shares representing 37.02% of all of the issued and outstanding common shares of Medicago. Assuming the exercise of all warrants comprising the units acquired by PM Investments, when calculated after giving effect to the Offering on a non-fully diluted basis the holding of PM Investments would then represent 38.53%. Based on the total number of common shares issued and outstanding described in the Prospectus Supplement No. 3 dated March 28, 2011 filed on SEDAR by Medicago in connection with the Offering, PM Investments remains the largest shareholder of Medicago after the Offering. This most recent acquisition of units was made for investment purposes. PMI may, subject to market conditions and in accordance with applicable securities laws, make additional investments in or dispositions of securities of Medicago, including additional purchases of Medicago common shares. Philip Morris International Inc. Philip Morris International Inc. (PMI) is the leading international tobacco company, with seven of the world's top 15 brands, including Marlboro, the number one cigarette brand worldwide. PMI's products are sold in approximately 180 countries. In 2010, the company held an estimated 16.0% share of the total international cigarette market outside of the U.S., or 27.6% excluding the People's Republic of China and the U.S. For more information, see www.pmi.com. Philip Morris International Inc.Investor Relations:New York: +1 (917) 663 2233Lausanne: +41 (0)58 242 4666orMedia:Lausanne: +41 (0)58 242 4500